Carotid stenting in high-risk patients: Design and rationale of the SAPPHIRE trial

Cleveland Clinic Journal of Medicine

Volumn 71, Issue SUPPL.1, 2003, Pages

  Yadav, Jay S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPLASTY; ARTICLE; CAROTID ARTERY DISEASE; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG CONTRAINDICATION; HUMAN; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; STENT;

ANGIOPLASTY; CAROTID ARTERY DISEASES; ENDARTERECTOMY, CAROTID; HUMANS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; STENTS;

EID: 84884572267     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.71.Suppl_1.S45     Document Type: Article

References (5)

1. Bettmann MA, Katzen BT, Whisnant J, et al. Carotid stenting and angioplasty: a statement for healthcare professionals from the Councils on Cardiovascular Radiology, Stroke, Cardio-Thoracic and Vascular Surgery, Epidemiology and Prevention, and Clinical Cardiology, American Heart Association. Circulation 1998; 97:121-123.
2. Ouriel K, Hertzer NR, Beven EG, et al. Preprocedural risk stratification: identifying an appropriate population for carotid stenting. J Vasc Surg 2001; 33:728-732.
3. Stukenborg GJ. Comparison of carotid endarterectomy outcomes from randomized controlled trials and Medicare administrative databases. Arch Neurol 1997; 54:826-832.
4. Wennberg DE, Lucas FL, Birkmeyer JD, Bredenberg CE, Fisher ES. Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics. JAMA 1998; 279:1278-1281.
5. Cebul RD, Snow RJ, Pine R, Hertzer NR, Norris DG. Indications, outcomes, and provider volumes for carotid enterectomy. JAMA 1998; 279:1282-1287.